Literature DB >> 2786882

Platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor I regulate specific cell-cycle parameters of human diploid fibroblasts in serum-free culture.

Y Chen1, P S Rabinovitch.   

Abstract

The growth regulation of human diploid fibroblasts by platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin-like growth factor I (IGF-I) (somatomedin C), dexamethasone, and transferrin was investigated in a serum-free, chemically defined culture system. Cell-cycle kinetic parameters were determined using 5'-bromodeoxyuridine (BrdU) incorporation and flow cytometric analysis with the DNA-specific dye Hoechst 33258. We found that PDGF and EGF regulate the proportion of cells capable of entering the cell cycle from the quiescent state, with smaller effects upon the rate of cell transition from G1 into S phase. IGF-1, on the other hand, regulates the rate of cell exit from G1 without affecting the cycling fraction. Transferrin and dexamethasone showed less effect upon the cell-cycle kinetics under these culture conditions. The data provide functional evidence that PDGF and EGF regulate similar cell-kinetic parameters in human fibroblast cultures. IGF-I is functionally distinct from both PDGF and EGF in its role of regulating G1 exit rate without affecting the cycling fraction. These observations made by BrdU-Hoechst flow cytometric techniques provide a novel perspective on the regulatory effects exerted by different classes of growth factors, and suggest a mode of interdependence of these mitogens in regulating the net growth rate which could be a feature of growth regulation in vivo. These data also provide a different perspective on the regulation of the growth of fibroblast-like cells than that of the "competence/progression" cell-cycle model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786882     DOI: 10.1002/jcp.1041400108

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation.

Authors:  G Powis; M Seewald; M Hoke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin.

Authors:  G Fager; G Camejo; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

4.  Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation.

Authors:  B H Davis; U R Rapp; N O Davidson
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

5.  Epidermal growth factor primes intestinal epithelial cells for proliferative effect of insulin-like growth factor I.

Authors:  M D Duncan; L Y Korman; B L Bass
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

6.  Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.

Authors:  G Powis; M J Seewald; D Melder; M Hoke; C Gratas; T A Christensen; D E Chapman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Fructose-induced enhanced mitogenicity of diploid human cells: possible relationship with cell differentiation.

Authors:  C Wolfrom; N Kadhom; J Raulin; N Raynaud; M Gautier
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

8.  Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes.

Authors:  Masahiro Chiba; Yutaka Sanada; Shinya Kawano; Masayuki Murofushi; Ichiro Okada; Yasuo Yoshizawa; Akira Gomi; Masashi Yatsuzuka; Akira Toki; Yoshinori Hirai
Journal:  Pediatr Surg Int       Date:  2007-02-28       Impact factor: 2.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.